Actinium Pharmaceuticals (ATNM) Stock Chart & Stock Price History $1.17 -0.06 (-4.88%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.20 +0.03 (+2.65%) As of 02/21/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsTrends Actinium Pharmaceuticals Stock Price Performance 5 Day Performance+1.74%1 Month Performance-10.00%3 Month Performance-20.41%6 Month Performance-44.81%Year-To-Date Performance-7.14%1 Year Performance-81.63% Receive ATNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ATNM Stock Chart for Saturday, February, 22, 2025 ATNM Chart by TradingView Actinium Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$1.23$1.17-4.88%$1.26$1.17124,121 shs$36.50 million02/20/2025$1.17$1.23+5.13%$1.23$1.15130,783 shs$38.38 million02/19/2025$1.26$1.17-7.14%$1.28$1.17172,096 shs$36.50 million02/18/2025$1.15$1.26+9.57%$1.28$1.17318,230 shs$39.31 million02/17/2025$1.15$1.15$1.16$1.1294,159 shs$35.88 million02/14/2025$1.10$1.15+4.55%$1.16$1.1294,159 shs$35.88 million02/13/2025$1.09$1.10+0.92%$1.13$1.07174,853 shs$34.32 million02/12/2025$1.11$1.09-1.80%$1.12$1.07129,151 shs$34.01 million02/11/2025$1.13$1.11-1.77%$1.15$1.10190,110 shs$34.63 million02/10/2025$1.12$1.13+0.89%$1.16$1.12161,532 shs$35.26 million Get the Latest News and Ratings for ATNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$1.15$1.12-2.61%$1.18$1.11219,713 shs$34.94 million02/06/2025$1.23$1.15-6.50%$1.23$1.15125,665 shs$35.88 million02/05/2025$1.17$1.23+5.13%$1.23$1.17142,186 shs$38.38 million02/04/2025$1.18$1.17-0.85%$1.23$1.17143,621 shs$36.50 million02/03/2025$1.16$1.18+1.72%$1.18$1.10257,559 shs$36.82 million01/31/2025$1.22$1.16-4.92%$1.24$1.16266,188 shs$36.19 million01/30/2025$1.23$1.22-0.81%$1.26$1.18145,800 shs$38.06 million01/29/2025$1.29$1.23-4.65%$1.30$1.23133,854 shs$38.38 million01/28/2025$1.29$1.29$1.31$1.26160,791 shs$40.25 million01/27/2025$1.29$1.29$1.33$1.27123,157 shs$40.25 million01/24/2025$1.34$1.29-3.73%$1.35$1.28135,740 shs$40.25 million01/23/2025$1.32$1.34+1.52%$1.34$1.3069,848 shs$41.81 million01/22/2025$1.30$1.32+1.54%$1.35$1.30125,421 shs$41.18 million01/21/2025$1.40$1.30-7.14%$1.43$1.30270,049 shs$40.56 million01/20/2025$1.40$1.40$1.40$1.22453,900 shs$43.68 million Related Companies Seres Therapeutics Stock Price Chart Puma Biotechnology Stock Price Chart Coherus BioSciences Stock Price Chart Biomea Fusion Stock Price Chart Black Diamond Therapeutics Stock Price Chart Cabaletta Bio Stock Price Chart 2seventy bio Stock Price Chart Kyverna Therapeutics Stock Price Chart Sagimet Biosciences Stock Price Chart Inventiva Stock Price Chart Receive ATNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ATNM) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actinium Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Actinium Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
